Laboratory Introduction

G2GBIO is conducting ongoing research for the development of next-generation biopharmaceuticals

R&D Center

We are researching various long-acting microsphere injectables by applying InnoLAMP technology

At G2GBIO's R&D Center, we conduct long-acting pharmaceutical formulation research, analytical studies, and production process studies for various APIs. Through these studies, we have successfully developed optimized release duration, release profiles and commercial production processes for each drug, taking into account their unique characteristics.

KBIO

G2GBIO possess our own dedicated GMP facility

G2GBIO have our own exclusive and dedicated GMP facility located in KBIO Health in Chungcheongbuk-do Osong, which is capable of manufacturing clinical trial and early commercial pharmaceutical products.

Certificate

G2GBIO is conducting ongoing research for the development of next-generation biopharmaceuticals.

  • Year
  • Issued Countries
  • Application/Patent number
  • Title
  • Patent Certificate
1 2 3